Laurus Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
1,001.35
1.7 (0.17%)
BSENSE

Jan 28

BSE+NSE Vol: 20.14 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Glenmark Pharma
Laurus Labs
Ipca Labs
J B Chemicals &
Alkem Lab
Ajanta Pharma
Aurobindo Pharma
Biocon
Abbott India
Glaxosmi. Pharma
Anthem Bioscienc

Why is Laurus Labs Ltd ?

1
High Management Efficiency with a high ROCE of 16.75%
2
With a growth in Net Profit of 179.34%, the company declared Outstanding results in Dec 25
  • The company has declared positive results for the last 5 consecutive quarters
  • ROCE(HY) Highest at 16.28%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 12.38 times
  • DEBT-EQUITY RATIO(HY) Lowest at 0.46 times
3
Market Beating performance in long term as well as near term
  • Along with generating 95.77% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Laurus Labs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Laurus Labs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Laurus Labs
95.77%
2.92
32.83%
Sensex
8.49%
0.76
11.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.65%
EBIT Growth (5y)
2.57%
EBIT to Interest (avg)
6.87
Debt to EBITDA (avg)
1.89
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
0.92
Tax Ratio
25.69%
Dividend Payout Ratio
26.86%
Pledged Shares
2.69%
Institutional Holding
38.95%
ROCE (avg)
17.62%
ROE (avg)
16.67%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
64
Industry P/E
32
Price to Book Value
11.25
EV to EBIT
46.15
EV to EBITDA
33.33
EV to Capital Employed
8.08
EV to Sales
8.36
PEG Ratio
0.20
Dividend Yield
0.16%
ROCE (Latest)
14.92%
ROE (Latest)
14.23%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

32What is working for the Company
ROCE(HY)

Highest at 16.28%

OPERATING PROFIT TO INTEREST(Q)

Highest at 12.38 times

DEBT-EQUITY RATIO(HY)

Lowest at 0.46 times

NET SALES(Q)

Highest at Rs 1,778.29 cr

PBDIT(Q)

Highest at Rs 480.21 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 27.00%

PBT LESS OI(Q)

Highest at Rs 320.80 cr.

PAT(Q)

Highest at Rs 251.66 cr.

EPS(Q)

Highest at Rs 4.66

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Laurus Labs

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 320.80 cr has Grown at 164.56%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 251.66 cr has Grown at 172.7%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 12.38 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 1,778.29 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 1,778.29 cr has Grown at 25.67%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 480.21 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 27.00%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 320.80 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 251.66 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 4.66
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Lowest at 0.46 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio